• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form DFAN14A filed by Enhabit Inc.

    6/17/24 4:47:50 PM ET
    $EHAB
    Medical/Nursing Services
    Health Care
    Get the next $EHAB alert in real time by email
    DFAN14A 1 dfan14a12397015_06172024.htm

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    SCHEDULE 14A

    (Rule 14a-101)

     

    INFORMATION REQUIRED IN PROXY STATEMENT

     

    SCHEDULE 14A INFORMATION

     

    Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

     

    (Amendment No. )

     

    Filed by the Registrant ☐

     

    Filed by a Party other than the Registrant ☒

     

    Check the appropriate box:

     

    ☐Preliminary Proxy Statement

     

    ☐Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

     

    ☐Definitive Proxy Statement

     

    ☒Definitive Additional Materials

     

    ☐Soliciting Material Under § 240.14a-12

      

    ENHABIT, INC.

    (Name of Registrant as Specified In Its Charter)

     

    AREX CAPITAL MASTER FUND, LP

    AREX CAPITAL PARTNERS, LP

    AREX CAPITAL, LTD.

    AREX CAPITAL GP, LLC

    AREX CAPITAL MANAGEMENT, LP

    AREX CAPITAL MANAGEMENT GP, LLC

    ANDREW RECHTSCHAFFEN

    JAMES T. CORCORAN

    MEGAN AMBERS

    MAXINE HOCHHAUSER

    MARK W. OHLENDORF

    ANNA-GENE O’NEAL

    DR. GREGORY S. SHEFF

    JUAN VALLARINO

    (Name of Persons(s) Filing Proxy Statement, if other than the Registrant)

     

     

     

    Payment of Filing Fee (Check all boxes that apply):

     

    ☒No fee required

     

    ☐Fee paid previously with preliminary materials

      

    ☐Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11

     

     

     

    AREX Capital Master Fund, LP, an exempted limited partnership organized under the laws of the Cayman Islands, together with the other participants named herein (collectively, “AREX”), has filed a definitive proxy statement and accompanying WHITE universal proxy card with the Securities and Exchange Commission (“SEC”) to be used to solicit votes for the election of its slate of highly-qualified director nominees at the 2024 annual meeting of stockholders (the “Annual Meeting”) of Enhabit, Inc., a Delaware corporation (the “Company”).

    Item 1: On June 17, 2024, AREX issued an open letter to its fellow stockholders titled, “AREX Sets the Record Straight”, a copy of which is attached hereto as Exhibit 1 and incorporated herein by reference.

    Item 2: On June 17, 2024, AREX Capital Master issued the following press release:

    AREX CAPITAL SETS THE RECORD STRAIGHT REGARDING ENHABIT’S MISLEADING ASSERTIONS

    Reiterates Need for Boardroom Change This Year Following Enhabit’s Staggering Operating and Financial Underperformance

    Believes Enhabit’s Stockholders Deserve Leadership That Can Navigate Challenging External Environment

    Disappointed by Board’s Continued Refusal to Engage

    Urges Stockholders to Vote FOR the AREX Nominees—Who are Best Positioned to Rehabilitate Enhabit—on the WHITE Proxy Card

    New York (June 17, 2024) — AREX Capital Management, LP (together with its affiliates, “AREX” or “we”), the beneficial owner of approximately 4.9% of the outstanding common shares of Enhabit, Inc. (NYSE: EHAB) (“Enhabit”), today issued an open letter to its fellow stockholders regarding the misleading statements in Enhabit’s recent communications.

    The full text of the letter can be found here: AREX Sets the Record Straight.1

    We believe voting for all seven of AREX’s nominees on the WHITE proxy card at the upcoming 2024 Annual Meeting of Stockholders is the best way to ensure that Enhabit can remain a leader in the home health and hospice industries with a Board that is capable of effective management oversight and is accountable to stockholders.

    Stockholders are encouraged to visit www.rehabEHAB.com for additional information.

    About AREX

    AREX Capital Management, LP is a value-oriented investment firm based in New York City. AREX takes a long-term, opportunistic approach to investing and focuses primarily on publicly traded companies with significant, unrealized potential.


    1 https://www.rehabehab.com/_files/ugd/4b2160_4ab041adcfc9414fb3250bc93918baea.pdf

     

     

    Investor Contact

    Saratoga Proxy Consulting
    John Ferguson
    (212) 257-1311
    [email protected]

    Media Contact

    Longacre Square Partners
    Greg Marose / Charlotte Kiaie
    (646) 386-0091
    [email protected]

     

    Item 3: AREX posted the following material to www.rehabehab.com: 

    A close-up of a document

Description automatically generated

     

    A close-up of a press release

Description automatically generated

     

     

    A screenshot of a computer

Description automatically generated

     

    A close-up of a letter

Description automatically generated

     

    A close-up of a document

Description automatically generated

     

    A close-up of a document

Description automatically generated

     

    A screenshot of a computer

Description automatically generated

     

    A close-up of a letter

Description automatically generated

     

    Close-up of a document

Description automatically generated

     

    A screenshot of a website

Description automatically generated

     

    Close-up of a letter

Description automatically generated

     

    A close-up of a document

Description automatically generated

     

     

    Get the next $EHAB alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $EHAB

    DatePrice TargetRatingAnalyst
    12/9/2024$8.25 → $9.50Hold → Buy
    Jefferies
    5/14/2024$8.50Underperform → Market Perform
    Leerink Partners
    5/9/2024$14.00 → $8.75Buy → Hold
    Jefferies
    3/7/2024$9.50Sell → Neutral
    UBS
    12/12/2023$12.00Market Perform
    TD Cowen
    6/20/2023$10.00Underperform
    SVB Securities
    3/16/2023$15.00Neutral
    Goldman
    12/13/2022$18.00Market Perform
    CJS Securities
    More analyst ratings